SABCS 2016 Press Conference December 7
Refers to Presentation S1-05. Mamounas EP, Bandos H, Lembersky BC, Geyer CE, et al.: A randomized, double-blinded, placebo-controlled clinical trial to evaluate extended adjuvant endocrine therapy (5 years of letrozole) in postmenopausal women with hormone-receptor positive breast cancer who have completed previous adjuvant endocrine therapy: Initial results of NRG oncology/NSABP B-42
